Bibliographic Details
| Title: |
Efficacy and safety of darunavir-ritonavir at week 48 in treatment-experienced patients with HIV-1 infection in POWER 1 and 2: a pooled subgroup analysis of data from two randomised trials. |
| Authors: |
Clotet B (AUTHOR), Bellos N (AUTHOR), Molina JM (AUTHOR), Cooper D (AUTHOR), Goffard JC (AUTHOR), Lazzarin A (AUTHOR), Wöhrmann A (AUTHOR), Katlama C (AUTHOR), Wilkin T (AUTHOR), Haubrich R (AUTHOR), Cohen C (AUTHOR), Farthing C (AUTHOR), Jayaweera D (AUTHOR), Markowitz M (AUTHOR), Ruane P (AUTHOR), Spinosa-Guzman S (AUTHOR), Lefebvre E (AUTHOR), POWER 1 and 2 study groups (CORPORATE AUTHOR) |
| Source: |
Lancet. 4/7/2007, Vol. 369 Issue 9568, p1169-1178. 10p. |
| Database: |
Psychology and Behavioral Sciences Collection |
